Literature DB >> 12169454

IGF-I and insulin regulate eIF4F formation by different mechanisms in muscle and liver in the ovine fetus.

Weihua Shen1, Daniel Mallon, David W Boyle, Edward A Liechty.   

Abstract

The mechanisms by which insulin-like growth factor I (IGF-I) and insulin regulate eukaryotic initiation factor (eIF)4F formation were examined in the ovine fetus. Insulin infusion increased phosphorylation of eIF4E-binding protein (4E-BP1) in muscle and liver. IGF-I infusion did not alter 4E-BP1 phosphorylation in liver. In muscle, IGF-I increased 4E-BP1 phosphorylation by 27%; the percentage in the gamma-form in the IGF-I group was significantly lower than that in the insulin group. In liver, only IGF-I increased eIF4G. Both IGF-I and insulin increased eIF4E. eIF4G binding in muscle, but only insulin decreased the amount of 4E-BP1 associated with eIF4E. In liver, only IGF-I increased eIF4E. eIF4G binding. Insulin increased the phosphorylation of p70 S6 kinase (p70(S6k)) in both muscle and liver and protein kinase B (PKB/Akt) in muscle, two indicative signal proteins in the phosphatidylinositol (PI) 3-kinase pathway. IGF-I increased PKB/Akt phosphorylation in muscle but had no effect on p70(S6k) phosphorylation in muscle or liver. We conclude that insulin and IGF-I modulate eIF4F formation; however, the two hormones have different regulatory mechanisms. Insulin increases phosphorylation of 4E-BP1 and eIF4E. eIF4G binding in muscle, whereas IGF-I regulates eIF4F formation by increasing total eIF4G. Insulin, but not IGF-I, decreased 4E-BP1 content associated with eIF4E. Insulin regulates translation initiation via the PI 3-kinase-p70(S6k) pathway, whereas IGF-I does so mainly via mechanisms independent of the PI 3-kinase-p70(S6k) pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169454     DOI: 10.1152/ajpendo.00570.2001

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  8 in total

1.  Insulin action on protein synthesis and its association with eIF5A expression and hypusination.

Authors:  André Ricardo Gomes de Proença; Karina Danielle Pereira; Leticia Meneguello; Leticia Tamborlin; Augusto Ducati Luchessi
Journal:  Mol Biol Rep       Date:  2018-12-05       Impact factor: 2.316

2.  Prolonged infusion of amino acids increases leucine oxidation in fetal sheep.

Authors:  Anne M Maliszewski; Monika M Gadhia; Meghan C O'Meara; Stephanie R Thorn; Paul J Rozance; Laura D Brown
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-27       Impact factor: 4.310

3.  Acute supplementation of amino acids increases net protein accretion in IUGR fetal sheep.

Authors:  Laura D Brown; Paul J Rozance; Stephanie R Thorn; Jacob E Friedman; William W Hay
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-05-29       Impact factor: 4.310

4.  Reduction in amino-acid-induced anti-hypothermic effects during general anesthesia in ovariectomized rats with progesterone replacement.

Authors:  Masahiro Kanazawa; Mariko Watanabe; Toshiyasu Suzuki
Journal:  J Anesth       Date:  2015-09-15       Impact factor: 2.078

Review 5.  Impact of placental insufficiency on fetal skeletal muscle growth.

Authors:  Laura D Brown; William W Hay
Journal:  Mol Cell Endocrinol       Date:  2016-03-16       Impact factor: 4.102

6.  Insulin is required for amino acid stimulation of dual pathways for translational control in skeletal muscle in the late-gestation ovine fetus.

Authors:  Laura D Brown; Paul J Rozance; James S Barry; Jacob E Friedman; William W Hay
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-21       Impact factor: 4.310

Review 7.  Endocrine regulation of fetal skeletal muscle growth: impact on future metabolic health.

Authors:  Laura D Brown
Journal:  J Endocrinol       Date:  2014-04-22       Impact factor: 4.286

8.  A physiological increase in insulin suppresses muscle-specific ubiquitin ligase gene activation in fetal sheep with sustained hypoglycemia.

Authors:  Laura D Brown; Stephanie R Thorn; Meghan C O'Meara; Jinny R Lavezzi; Paul J Rozance
Journal:  Physiol Rep       Date:  2014-06-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.